Percutaneous Aortic Valve Replacement

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano
M. Burden of valvular heart diseases: a population-based study. Lancet.
2006;368:1005-1011.
2. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T et al. Heart
disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.
2006;113:e85-e151.
3. Goodney PP, O’Connor GT, Wennberg DE, et al: Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? Ann
Thorac Surg. 2003;76:1131-1136.
4 Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E et al:
Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE
multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15:816–
822.
5. Culliford AT, Galloway AC, Colvin SB: Aortic valve replacement for aortic
stenosis in persons aged 80 years and over. Am J Cardiol. 1991;67:1256–1260.
6. Kvidal P, Bergström R, Hörte L-G, Stahle E. Observed and relative survival after
aortic valve replacement. J Am Coll Cardiol. 2000;35:747–756.
7. Sundt TM, Bailey MS, Moon MR, Mendeloff EN, Huddleston CB, Pasque MK,
et al: Quality of life after aortic valve replacement at the age of 80 years. Circulation. 2000;102:III70-III74.
8. Mullany CJ: Aortic valve surgery in the elderly. Cardiol Rev. 2000;8:333-339.
9. Mortasawi A, Gehle S, Schröder T, Ennker IC, Rosendahl U, Dalladaku F et al.
Aortic valve replacement in 80- and over 80 year-old patients. Z Gerontol Geriatr.
2000;33:438-446.
10. Bloomstein LZ, Gielchinsky I, Bernstein AD, Parsonnet V, Saunders C,
Karanam R, et al. Aortic valve replacement in geriatric patients: determinants of
in-hospital mortality. Ann Thorac Surg. 2001;71:597-600.
11. Kolh P, Kerzmann A, Lahaye L. Cardiac surgery in octogenarians; perioperative
outcome and long-term results. Eur Heart J. 2001;22:1235-1243.
12. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, Taylor AM et al. Risk stratification, systematic classification and anticipatory management strategies for stent fracture after percutaneous pulmonary valve
implantation. Circulation. 2007;115:1392-1397.
13. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW et
al: A prospective survey of patients with valvular heart disease in Europe: the Euro
Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24: 1231–1243.
14 Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations
on the etiology of aortic valve disease: A surgical pathologic study of 236 cases from
1990. Hum Pathol. 1993;24:1330–1338.
15 Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, et al. Percutaneous transcatheter implantation of heart valve prosthesis for the treatment of
end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol.
2004;43:698–703.
16. Webb JG. Percutaneous Aortic Valve Replacement Will Become a Common
Treatment for Aortic Valve Disease. Am Coll Cardiol Intv. 2008;1:122-126.
17. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results
with implantation by catheter technique in closed chest pigs. Eur Heart J.
1992;13:704-708.
18. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et al: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic
stenosis: first human case description. Circulation. 2002;106:3006-3008.
19. Sochman J, Peregrin JH, Pavcnik D, Timmermans H, Rosch J. Percutaneous
transcatheter aortic disc valve prosthesis implantation: a feasibility study. Cardiovasc Intervent Radiol. 2000; 23:384–388.
20. Boudjemline Y, Bonhoeffer P. Steps toward percutaneous aortic valve replacement. Circulation. 2002;105:775–778.
21. Lutter G, Kuklinski D, Berg G, Von Samson P, Martin J, Handke M et al. Percutaneous aortic valve replacement: an experimental study. J Thorac Cardiovasc
Gradient = 4(velocity)² mmHg
s Fig. 2. Antegrade
approach.
REVIEW
Surg. 2002;123:768–776.
22. Webb JG, Munt B, Makkar RR, Naqvi TZ, Dang N. Percutaneous stentmounted valve for treatment of aortic or pulmonary valve disease. Catheter Cardiovasc Interv. 2004;63:89–93.
23. Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhoff T, Sauren B,. First
report on a human percutaneous transluminal implantation of a self-expanding
valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv. 2005;66:465–469.
24. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, et al.
Percutaneous implantation of the CoreValve self-expanding valve prosthesis in
high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006; 114:1616–1624.
25. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et
al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006; 113:842–850.
26. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P et al.
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve
prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol.
2007;50:69–76.
27. Singh IM, Shishehbor MH, Christofferson RD, Tuzcu EM, Kapadia SR Percutaneous treatment of aortic valve stenosis Cleve Clin J Med. 2008 Nov;75(11):805-
1
28. Bonow,R, Carabello B, de Leon C, Edmunds LH, Fedderly BJ, Freed MD,
Gaasch WH, ACC/AHA guidelines for the management of patients with valvular
heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients
with Valvular Heart Disease). J Am Coll Cardiol. 1998;32:1486-1588F.
29. Webb, MD. Transcatheter Percutaneous and Transapical Aortic Valve Replacement. Semin Thorac Cardiovasc Surg. 2007;19:304-310.
30. Hanzel GS, Harrity PJ, Schreiber TL, O'Neill WW. Retrograde percutaneous
aortic valve implantation for critical aortic stenosis. Cathet Cardiovasc Interv.
2005;64:322-326.
31 Munt B, Webb J. Percutaneous valve repair and replacement techniques. Heart.
2006;92:1369-1372.
32. Berry C, Asgar A, Lamarche Y, Marcheix B, Couture P, Basmadjian A,, et al.
Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F
Core Valve Revalving System. Cathet Cardiovasc Interv. 2007;70:610-616.
33. Eltchaninoff H, Tron C, Cribier A. Percutaneous implantation of aortic valve
prosthesis in patients with calcific aortic stenosis: technical advances, clinical results and future strategies. J Invasive Cardiol. 2006;19:S88-S96.
34. Walther T, Dewey T, Wimmer-Greinecker G, Doss M, Hambrecht R, Schuler G
et al. Transapical approach for sutureless stent- fixed aortic valve implantation: experimental results. Eur J Cardio-Thorac Surg. 2006;29:703–8.
35. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, et al.
Transapical transcatheter aortic valve implantation in humans - Initial clinical experience. Circulation. 2006;114:591–6.
36. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R et al.
Percutaneous transarterial aortic valve replacement in selected high risk patients
with aortic stenosis. Circulation. 2007;116:755-763.
37 Hanzal G et al. Complications of percutaneous aortic valve replacement: experience with the Cribier-EdwardsTM percutaneous heart valve. Euro Intervention
38. Otto CM, Mickel MC, Kennedy JW, Alderman EL, Bashore TM, Block PC, et
al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of
valvular aortic stenosis. Circulation. 1994;89(2):642-650.
39. Holmes DR Jr, Nishimura RA, Reeder GS. In hospital mortality after balloon
aortic valvuloplasty: frequency and associated factors J Am Coll Cardiol.
1991;17(1):189-192.
40. O’ Neill WW. Predictors of long-term survival after percutaneous aortic valvuloplasy: report of the Mansfield Scientific Balloon Aortic Valvuloplasy Registry. J
Am Coll Cardiol. 1991;17(1):193-198.
41. Kuntz RE, Tosteson AN, Berman AD, Goldman L, Gordon PC, Leonard BM et
al. Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J
Med. 1991;325(1):17-23.
42. Kumar GP, Mathew L. Design for Percutaneous Aortic Valve Stent, International Conference on Biotechnology Proceedings; 20082 VIT University,
43. Nollert G. Surgery opens up new treatment methods. Axiom Innovations 2008.
Available from .siemens.com/healthcare-magazine.
44. Thomas M. Trans-catheter Aortic Valve Replacement: a UK update.Guys and
St Thomas’ Hospital
45. Kumar GP, Mathew L. Novel Stent Design for Percutaneous Aortic Valve Replacement - IFMBE Proceedings, 4th Kuala Lumpur International Conference on
Biomedical Engineering; 2008; Springerlink.
46. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D et al.
Treatment of calcific aortic stenosis with the percutaneous heart valve; mid-term
follow-up from the initial feasibility studies; the French experience. J Am Coll Cardiol. 2006;27:1214-1223.
47 Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA
et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiography. 2003;16:777–802.
48.Lutter G, Ardehali R, Cremer J. Percutaneous Valve Replacement: Current
State and Future Prospects. Ann Thorac Surg. 2004 Dec;78(6):2199-206